The value of artificial intelligence combined with multimodal data analysis in tumor immunotherapy and targeted therapy
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2026
DOI: 10.1016/j.bbcan.2026.189562 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026. Verfasst von Dan Lv und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Hubei Province Clinical Research Center for Major Respiratory Diseases, Key Laboratory of Respi…. Hauptthemen laut MEDLINE: Artificial Intelligence, Immunotherapy, Neoplasms, Molecular Targeted Therapy. Die Arbeit nennt 181 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The advent of immunotherapy and targeted therapy has revolutionized oncology treatment in recent years, marking a transformative shift toward precision medicine. Artificial intelligence (AI) technology has played a pivotal role in tumor immunotherapy, targeted therapy, and related fields, by enhancing treatment efficacy prediction, identifying novel targets, and enabling personalized therapeutic strategies. In its early stages, AI development relied primarily on unimodal data processing architectures, which were limited to analyzing single data types and thus constrained in functionality. However, recent breakthroughs in data acquisition and integration have ushered in a new era of multimodal data fusion in oncology. Consequently, the integration of AI with multimodal data analytics now supports improved diagnostic accuracy, more precise prognosis prediction, and optimized individualized treatment planning-particularly in tumor immunotherapy and targeted therapy. Concurrently, this rapidly evolving domain faces pressing challenges, including data scarcity and lack of standardization, difficulty in aligning multimodal data, and the opaque, "black-box" nature of complex deep-learning models. Therefore, in this review, we aimed to summarize common AI technologies used in tumor diagnosis and treatment, multimodal data sources and fusion methods, applications of AI combined with multimodal data analysis in tumor immunotherapy and targeted therapy, and the key challenges currently facing this integrated approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, Hubei Province Clinical Research Center for Major Respiratory Diseases, Key Laboratory of Respiratory Diseases of National Health Commission, State Key Laboratory fo…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Lv, D., Wang, S., Xiao, W., Xu, J., & Jin, Y. (2026). The value of artificial intelligence combined with multimodal data analysis in tumor immunotherapy and targeted therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2026.189562
Vancouver
Lv D, Wang S, Xiao W, Xu J, Jin Y. The value of artificial intelligence combined with multimodal data analysis in tumor immunotherapy and targeted therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2026. doi:10.1016/j.bbcan.2026.189562
BibTeX
@article{Lv2026,
author = {Lv, Dan and Wang, Sufei and Xiao, Wenjing and Xu, Juanjuan and Jin, Yang},
title = {The value of artificial intelligence combined with multimodal data analysis in tumor immunotherapy and targeted therapy},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2026},
doi = {10.1016/j.bbcan.2026.189562}
}
EUVIMED